Upper Body Pain and Functional Disorders in Patients With Breast Cancer

PM and R

Volumn 6, Issue 2, 2014, Pages 170-183

  Stubblefield, Michael D ^a   Keole, Nandita ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; FEMALE; HUMANS; PAIN; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; QUALITY OF LIFE;

EID: 84894242092     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2013.08.605     Document Type: Review

References (101)

1. Hayes S.C., Johansson K., Stout N.L., et al. Upper-body morbidity after breast cancer: Incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer 2012, 118(8 suppl):2237-2249.
2. Karki A., Simonen R., Malkia E., Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. JRehabil Med 2005, 37:180-188.
3. Lucci A., McCall L.M., Beitsch P.D., et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons oncology Group trial Z0011. JClin Oncol 2007, 25:3657-3663.
4. Albert U.S., Koller M., Kopp I., Lorenz W., Schulz K.D., Wagner U. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: Results from a population-based cohort study. Breast Cancer Res Tr 2006, 100:285-292.
5. Arndt V., Stegmaier C., Ziegler H., Brenner H. Apopulation-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer 2006, 107:2496-2503.
6. Engel J., Kerr J., Schlesinger-Raab A., Sauer H., Holzel D. Axilla surgery severely affects quality of life: Results of a 5-year prospective study in breast cancer patients [erratum appears in Breast Cancer Res Treat 2003;80:233]. Breast Cancer Res Treat 2003, 79:47-57.
7. Ernst M.F., Voogd A.C., Balder W., Klinkenbijl J.H.G., Roukema J.A. Early and late morbidity associated with axillary levels I-III dissection in breast cancer. JSurg Oncol 2002, 79:151-155.
8. Gill G., Australasian S.T.G.R. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A randomized controlled surgical trial. Ann Surg Oncol 2009, 16:266-275.
9. Hayes S.C., Rye S., Battistutta D., Newman B. Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema. Lymphology 2010, 43:178-187.
10. Husted Madsen A., Haugaard K., et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: A study from the Danish Breast Cancer Cooperative Group. Breast 2008, 17:138-147.
11. Janz N.K., Mujahid M., Lantz P.M., et al. Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res 2005, 14:1467-1479.
12. Lauridsen M.C., Torsleff K.R., Husted H., Erichsen C. Physiotherapy treatment of late symptoms following surgical treatment of breast cancer. Breast 2000, 9:45-51.
13. Leidenius M., Leppanen E., Krogerus L., von Smitten K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003, 185:127-130.
14. Mansel R.E. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial [erratum appears in J Natl Cancer Inst 2006;98:876]. JNatl Cancer Inst 2006, 98:599-609.
15. McCredie M.R.E., Dite G.S., Porter L., et al. Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast 2001, 10:515-522.
16. Paskett E.D., Naughton M.J., Mccoy T.P., Case L.D., Abbott J.M. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidem Biomar 2007, 16:775-782.
17. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. JClin Oncol 2005, 23:4312-4321.
18. Rietman J.S., Dijkstra P.U., Geertzen J.H.B., et al. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma. Cancer 2003, 98:690-696.
19. Rietman J.S., Geertzen J.H.B., Hoekstra H.J., et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 2006, 32:148-152.
20. Thomas-MacLean R.L., Hack T., Kwan W., Towers A., Miedema B., Tilley A. Arm morbidity and disability after breast cancer: New directions for care. Oncol Nurs Forum 2008, 35:65-71.
21. Ronka R., von Smitten K., Tasmuth T., Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005, 14:28-36.
22. So W.K., Marsh G., Ling W.M., et al. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: A multicenter study. Oncol Nurs Forum 2009, 36:E205-E214.
23. Yang E.J., Park W.B., Seo K.S., Kim S.W., Heo C.Y., Lim J.Y. Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: A prospective cohort study. JSurg Oncol 2010, 101:84-91.
24. Janz N.K., Mujahid M., Chung L.K., et al. Symptom experience and quality of life of women following breast cancer treatment. JWomens Health 2007, 16:1348-1361.
25. Schmitz K.H., Speck R.M., Rye S.A., DiSipio T., Hayes S.C. Prevalence of breast cancer treatment sequelae over 6 years of follow-up: The Pulling Through Study. Cancer 2012, 118(suppl 8):2217-2225.
26. Stubblefield M.D., Custodio C.M. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil 2006, 87(3 suppl 1):S96-S99. quiz S100-S101.
27. Schnur J.B., Love B., Scheckner B.L., Green S., Wernicke A.G., Montgomery G.H. Asystematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. Am J Clin Oncol 2011, 34:529-536.
28. Ebaugh D., Spinelli B., Schmitz K.H. Shoulder impairments and their association with symptomatic rotator cuff disease in breast cancer survivors. Med Hypotheses 2011, 77:481-487.
29. McNeely M.L., Binkley J.M., Pusic A.L., Campbell K.L., Gabram S., Soballe P.W. Aprospective model of care for breast cancer rehabilitation: Postoperative and postreconstructive issues. Cancer 2012, 118(suppl 8):2226-2236.
30. Cheville A.L., Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. JSurg Oncol 2007, 95:409-418.
31. Herrera J.E., Stubblefield M.D. Rotator cuff tendonitis in lymphedema: A retrospective case series. Arch Phys Med Rehabil 2004, 85:1939-1942.
32. Hegedus E.J., Goode A., Campbell S., et al. Physical examination tests of the shoulder: A systematic review with meta-analysis of individual tests. Br J Sports Med 2008, 42:80-92.
33. Itoi E., Kido T., Sano A., Urayama M., Sato K. Which is more useful, the "full can test" or the "empty can test," in detecting the torn supraspinatus tendon?. Am J Sports Med 1999, 27:65-68.
34. MacDonald P.B., Clark P., Sutherland K. An analysis of the diagnostic accuracy of the Hawkins and Neer subacromial impingement signs. JShoulder Elbow Surg 2000, 9:299-301.
35. Leroux J.L., Thomas E., Bonnel F., Blotman F. Diagnostic value of clinical tests for shoulder impingement syndrome. Rev Rhum Engl Ed 1995, 62:423-428.
36. Jain N.B., Wilcox R.B., Katz J.N., Higgins L.D. Clinical examination of the rotator cuff. PM R 2013, 5:45-56.
37. Barr K.P. Rotator cuff disease. Phys Med Rehabil Clin N Am 2004, 15:475-491.
38. Ahmad A., Barrington S., Maisey M., Rubens R.D. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. Br J Cancer 1999, 79:478-482.
39. Stitik T.P., Foye P.M., Fossati J. Shoulder injections for osteoarthritis and other disorders. Phys Med Rehabil Clin N Am 2004, 15:407-446.
40. Chaudhury S., Gwilym S.E., Moser J., Carr A.J. Surgical options for patients with shoulder pain. Nat Rev Rheumatol 2010, 6:217-226.
41. Sheridan M.A., Hannafin J.A. Upper extremity: Emphasis on frozen shoulder. Orthop Clin North Am 2006, 37:531-539.
42. Robinson C.M., Seah K.T., Chee Y.H., Hindle P., Murray I.R. Frozen shoulder. JBone Joint Surg Br 2012, 94:1-9.
43. Stubblefield M.D. Radiation fibrosis syndrome: Neuromuscular and musculoskeletal complications in cancer survivors. PM R 2011, 3:1041-1054.
44. Buchbinder R., Green S., Youd J.M. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev 2003, 1. CD004016.
45. Buchbinder R., Green S., Youd J.M., Johnston R.V., Cumpston M. Arthrographic distension for adhesive capsulitis (frozen shoulder). Cochrane Database Syst Rev 2008, 1. CD007005.
46. Winters-Stone K.M., Schwartz A.L., Hayes S.C., Fabian C.J., Campbell K.L. Aprospective model of care for breast cancer rehabilitation: Bone health and arthralgias. Cancer 2012, 118(8 suppl):2288-2299.
47. Galantino M.L., Desai K., Greene L., Demichele A., Stricker C.T., Mao J.J. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias. Integr Cancer Ther 2011, 11:313-320.
48. Mao J.J., Su H.I., Feng R., et al. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 2011, 13. R8.
49. Crew K.D., Greenlee H., Capodice J., et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. JClin Oncol 2007, 25:3877-3883.
50. Gaillard S., Stearns V. Aromatase inhibitor-associated bone and musculoskeletal effects: New evidence defining etiology and strategies for management. Breast Cancer Res 2011, 13:205.
51. Robidoux A., Rich E., Bureau N.J., et al. Aprospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy. Curr Oncol 2011, 18:285-294.
52. Mrozek E., Shapiro C.L. Survivorship and complications of treatment in breast cancer. Clin Adv Hematol Oncol 2005, 3:211-222. 238.
53. Caridi J.M., Pumberger M., Hughes A.P. Cervical radiculopathy: A review. HSS J 2011, 7:265-272.
54. Stubblefield M.D., McNeely M.L., Alfano C.M., Mayer D.K. Aprospective surveillance model for physical rehabilitation of women with breast cancer: Chemotherapy-induced peripheral neuropathy. Cancer 2012, 118(8 suppl):2250-2260.
55. Yoon S.H. Cervical radiculopathy. Phys Med Rehabil Clin N Am 2011, 22:439-446. viii.
56. Mukai A., Kancherla V. Interventional procedures for cervical pain. Phys Med Rehabil Clin N Am 2011, 22:539-549. x.
57. Basho R., Bhalla A., Wang J.C. Neck pain from a spine surgeon's perspective. Phys Med Rehabil Clin N Am 2011, 22:551-555. x.
58. Jaeckle K.A. Neurologic manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 2010, 30:254-262.
59. Bajrovic A., Rades D., Fehlauer F., et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?. Radiother Oncol 2004, 71:297-301.
60. Johansson S., Svensson H., Larsson L.G., Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients-a long-term follow-up. Acta Oncol 2000, 39:373-382.
61. Hoeller U., Bonacker M., Bajrovic A., Alberti W., Adam G. Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool?. Strahlenther Onkol 2004, 180:650-654.
62. Rodger A. Should fewer fractions be the new standard for postoperative radiotherapy in patients with early breast cancer?. Breast 2010, 19:157-158.
63. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. NEngl J Med 2010, 362:513-520.
64. McDonald M.W., Godette K.D., Butker E.K., Davis L.W., Johnstone P.A. Long-term outcomes of IMRT for breast cancer: A single-institution cohort analysis. Int J Radiat Oncol Biol Phys 2008, 72:1031-1040.
65. Galecki J., Hicer-Grzenkowicz J., Grudzien-Kowalska M., Michalska T., Zalucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-a review. Acta Oncol 2006, 45:280-284.
66. Kamenova B., Braverman A.S., Schwartz M., et al. Effective treatment of the brachial plexus syndrome in breast cancer patients by early detection and control of loco-regional metastases with radiation or systemic therapy. Int J Clin Oncol 2009, 14:219-224.
67. Kori S.H., Foley K.M., Posner J.B. Brachial plexus lesions in patients with cancer: 100 cases. Neurology 1981, 31:45-50.
68. Stubblefield M.D., Burstein H.J., Burton A.W., et al. NCCN Task Force Report: Management of neuropathy in cancer. JNatl Compr Canc Netw 2009, 7:S1-S26.
69. Andersen K.G., Jensen M.B., Kehlet H., Gartner R., Eckhoff L., Kroman N. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel+ epirubicin and cyclophosphamide. Acta Oncol 2012, 51:1036-1044.
70. England J.D., Gronseth G.S., Franklin G., et al. Evaluation of distal symmetric polyneuropathy: The role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 2009, 39:116-125.
71. Page M.J., O'Connor D., Pitt V., Massy-Westropp N. Exercise and mobilisation interventions for carpal tunnel syndrome. Cochrane Database Syst Rev 2012, 6. CD009899.
72. Gelfman R., Melton L.J., Yawn B.P., Wollan P.C., Amadio P.C., Stevens J.C. Long-term trends in carpal tunnel syndrome. Neurology 2009, 72:33-41.
73. Mondelli M., Giannini F., Ballerini M., Ginanneschi F., Martorelli E. Incidence of ulnar neuropathy at the elbow in the province of Siena (Italy). JNeurol Sci 2005, 234:5-10.
74. Nishihori T., Choi J., DiGiovanna M.P., et al. Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer. Clin Breast Cancer 2008, 8:362-365.
75. Henry N.L., Jacobson J.A., Banerjee M., et al. Aprospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography. Cancer 2010, 116:4360-4367.
76. Sestak I., Sapunar F., Cuzick J. Aromatase inhibitor-induced carpal tunnel syndrome: Results from the ATAC trial. JClin Oncol 2009, 27:4961-4965.
77. Mieog J.S., Morden J.P., Bliss J.M., Coombes R.C., van de Velde C.J., Committee IESS Carpal tunnel syndrome and musculoskeletal symptoms inpostmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: A retrospective analysis of theIntergroup Exemestane Study. Lancet Oncol 2012, 13:420-432.
78. Vecht C.J. Arm pain in the patient with breast cancer. JPain Symptom Manage 1990, 5:109-117.
79. Ganel A., Engel J., Sela M., Brooks M. Nerve entrapments associated with postmastectomy lymphedema. Cancer 1979, 44:2254-2259.
80. American Association of Neuromuscular and Electrodiagnostic Medicine Needle EMG in certain uncommon clinical contexts. Muscle Nerve 2005, 31:398-399.
81. Cassileth B.R., Van Zee K.J., Yeung K.S., et al. Acupuncture in the treatment of upper-limb lymphedema: Results of a pilot study. Cancer 2013, 119:2455-2461.
82. Macdonald L., Bruce J., Scott N.W., Smith W.C., Chambers W.A. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 2005, 92:225-230.
83. Torres Lacomba M., Mayoral del Moral O., Coperias Zazo J.L., Gerwin R.D., Goni A.Z. Incidence of myofascial pain syndrome in breast cancer surgery: A prospective study. Clin J Pain 2010, 26:320-325.
84. Ramesh, Shukla N.K., Bhatnagar S. Phantom breast syndrome. Ind J Palliative Care 2009, 15:103-107.
85. Dijkstra P.U., Rietman J.S., Geertzen J.H. Phantom breast sensations and phantom breast pain: A 2-year prospective study and a methodological analysis of literature. Eur J Pain 2007, 11:99-108.
86. Hansen D.M., Kehlet H., Gartner R. Phantom breast sensations are frequent after mastectomy. Danish Med Bull 2011, 58. A4259.
87. Maher J., Refshauge K., Ward L., Paterson R., Kilbreath S. Change in extracellular fluid and arm volumes as a consequence of a single session of lymphatic massage followed by rest with or without compression. Supportive Care Cancer 2012, 20:3079-3086.
88. Czerniec S.A., Ward L.C., Refshauge K.M., et al. Assessment of breast cancer-related arm lymphedema-comparison of physical measurement methods and self-report. Cancer Invest 2010, 28:54-62.
89. Paskett E.D., Dean J.A., Oliveri J.M., Harrop J.P. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: A review. JClin Oncol 2012, 30:3726-3733.
90. E Lima M.T., E Lima J.G., de Andrade M.F., Bergmann A. Low-level laser therapy in secondary lymphedema after breast cancer: Systematic review. Lasers Med Sci 2013, [epub ahead of print].
91. Mehrara B.J., Zampell J.C., Suami H., Chang D.W. Surgical management of lymphedema: Past, present, and future. Lymphatic Res Biol 2011, 9:159-167.
92. Lin J.T., Stubblefield M.D. De Quervain's tenosynovitis in patients with lymphedema: A report of 2 cases with management approach. Arch Phys Med Rehabil 2003, 84:1554-1557.
93. Torres Lacomba M., Mayoral Del Moral O., Coperias Zazo J.L., Yuste Sanchez M.J., Ferrandez J.C., Zapico Goni A. Axillary web syndrome after axillary dissection in breast cancer: A prospective study. Breast Cancer Res Treat 2009, 117:625-630.
94. Moskovitz A.H., Anderson B.O., Yeung R.S., Byrd D.R., Lawton T.J., Moe R.E. Axillary web syndrome after axillary dissection. Am J Surg 2001, 181:434-439.
95. Khorana A.A. Cancer and thrombosis: Implications of published guidelines for clinical practice. Ann Oncol 2009, 20:1619-1630.
96. Soosainathan A., Moore H.M., Gohel M.S., Davies A.H. Scoring systems for the post-thrombotic syndrome. JVasc Surg 2013, 57:254-261.
97. Xing L., Adhikari V.P., Liu H., et al. Diagnosis prevention and treatment for PICC-related upper extremity deep vein thrombosis in breast cancer patients. Asia-Pacific J Clin Oncol 2012, 8:e12-e16.
98. Hernandez R.K., Sorensen H.T., Pedersen L., Jacobsen J., Lash T.L. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: A Danish population-based cohort study. Cancer 2009, 115:4442-4449.
99. Masmoudi A., Maaloul I., Turki H., et al. Erysipelas after breast cancer treatment (26 cases). Dermatol Online J 2005, 11:12.
100. El Saghir N.S., Otrock Z.K., Bizri A.R., Uwaydah M.M., Oghlakian G.O. Erysipelas of the upper extremity following locoregional therapy for breast cancer. Breast 2005, 14:347-351.
101. Kofteridis D.P., Valachis A., Koutsounaki E., et al. Skin and soft tissue infections in patients with solid tumours. ScientificWorldJournal 2012, 2012:804518.